000 01275 a2200337 4500
005 20250515173827.0
264 0 _c20100818
008 201008s 0 0 eng d
022 _a1365-2230
024 7 _a10.1111/j.1365-2230.2009.03236.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVestergaard, M E
245 0 0 _aSeborrhoeic keratoses appearing in sites of previous psoriasis plaques during treatment with efalizumab.
_h[electronic resource]
260 _bClinical and experimental dermatology
_cDec 2009
300 _ae564-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAnti-Inflammatory Agents
_xadverse effects
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aHumans
650 0 4 _aKeratosis, Seborrheic
_xchemically induced
650 0 4 _aLeg Dermatoses
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aKossard, S
700 1 _aMurrell, D F
773 0 _tClinical and experimental dermatology
_gvol. 34
_gno. 8
_gp. e564-6
856 4 0 _uhttps://doi.org/10.1111/j.1365-2230.2009.03236.x
_zAvailable from publisher's website
999 _c18931810
_d18931810